Inventor
CAO ZHIYUAN
CN30 patents
⚠️ This page may combine multiple inventors who share the name “CAO ZHIYUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD
17 patentsUS11104732B2Aug 31, 2021
Reducing immune inhibition induced by SIGLEC-15
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD6 citations83
US12297267B2May 13, 2025
Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US12240915B2Mar 4, 2025
Chimeric antigen receptor cells for treating solid tumor
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US12150960B2Nov 26, 2024
Modified cell expansion and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US12076343B2Sep 3, 2024
Engineered safety in cell therapy
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11834502B2Dec 5, 2023
Reducing immune inhibition induced by SIGLEC-15
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11739136B2Aug 29, 2023
Inducible dominant negative PD-1 and uses in adoptive cell therapy
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11701385B2Jul 18, 2023
Modulation of cell function for immunotherapy
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11566223B2Jan 31, 2023
Chimeric antigen receptor cell preparation and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD1 citations62
US11364289B2Jun 21, 2022
Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11235004B2Feb 1, 2022
Lymphocyte cell lines and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11161913B2Nov 2, 2021
Chimeric antigen receptor cells for treating solid tumor
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11932700B2Mar 19, 2024
Use of chimeric antigen receptor modified cells to treat cancer
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations61
US11944645B2Apr 2, 2024
Modified cell and use thereof in gene and cell therapy
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations59
US11833174B2Dec 5, 2023
Modified cell with enhanced functionality and cellular therapy thereof
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations59
US11970548B2Apr 30, 2024
Nanobody target GCC and uses in chimeric antigen receptor cell therapy
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations58
US11633427B2Apr 25, 2023
Vaccine and uses thereof in cell therapy
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations57
INNOVATIVE CELLULAR THERAPEUTICS CO LTD
9 patentsUS9932405B2Apr 3, 2018
Use of chimeric antigen receptor modified cells to treat cancer
INNOVATIVE CELLULAR THERAPEUTICS CO LTD13 citations91
US10561686B2Feb 18, 2020
Modified cell expansion and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS CO LTD17 citations85
US10493139B2Dec 3, 2019
Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
INNOVATIVE CELLULAR THERAPEUTICS CO LTD9 citations84
US10869888B2Dec 22, 2020
Modified cell expansion and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS CO LTD10 citations83
US10918667B2Feb 16, 2021
Modified cell expressing therapeutic agent and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS CO LTD2 citations72
US10793638B2Oct 6, 2020
Use of chimeric antigen receptor modified cells to treat cancer
INNOVATIVE CELLULAR THERAPEUTICS CO LTD2 citations71
US11981920B2May 14, 2024
Modified cell with enhanced migration capability
INNOVATIVE CELLULAR THERAPEUTICS CO LTD0 citations62
US11866494B2Jan 9, 2024
CAR T therapy through uses of co-stimulation
INNOVATIVE CELLULAR THERAPEUTICS CO LTD0 citations62
US10654934B2May 19, 2020
Use of chimeric antigen receptor modified cells to treat cancer
INNOVATIVE CELLULAR THERAPEUTICS CO LTD0 citations51